Carola Huber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Carola Huber has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Sherif A. Shazly
A Department of Obstetrics and Gynaecology, Division of Maternal-Fetal Medicine , Mayo Clinic , Rochester , MN , USA
2 shared publicationsEdgar Petru
Department of Obstetrics and Gynecology, Division of Gynecology, LKH University Hospital Graz, Graz, Austria
1 shared publicationEric Jelin
Assistant Professor and Director of Johns Hopkins Children's Center Fetal Program, Division of Pediatric Surgery, The Johns Hopkins Hospital, Baltimore, MD
1 shared publicationEva Sampl
Department of Internal Medicine, LKH Kirchdorf, Kirchdorf, Austria
1 shared publicationJosef Haas
Department of Obstetrics and Gynecology, Division of Gynecology, LKH University Hospital Graz, Graz, Austria
1 shared publicationRodrigo Ruano
Professor of Obstetrics & Gynecology, Pediatrics and Physiology & Biomedical Engineering, Chair of the Division of Maternal-Fetal Medicine, and Director of Mayo Clinic Fetal Section, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
1 shared publication
Latest Publications
- 15 July 2019
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 34 (10) , 1666-1672
Potential use of electrohysterography in obstetrics: a review article
Monitoring the uterine contraction during pregnancy is necessary to monitor labor progress, fetal and maternal well-being, and uterine activity. The aim of this review was to evaluate the performance of electrohysterography and to analyze the nature of uterine contraction. A search was undertaken using PubMed, Embase, and ClinicalTrials.gov database from 1 January 1950 to 1 November 2018. Search terms include: "Uterine" or "Uterus" or "Labor" or "Labour" and "electrical activity" or "electrohysterogram" or "electrohysterograph". Reviewing the literature, electrohysterography showed a higher sensitivity for uterine contraction detection and was independent of body mass index, abdominal wall thickness, or maternal position enabling monitoring obese patients as well. Electrohysterography can enhance uterine monitoring throughout labor because of its noninvasiveness, adhesive properties, and reduced obesity sensitiveness. Electrohysterography should be available to safely improve intrapartum monitoring instead of the invasive intrauterine pressure catheter.
- 15 July 2019
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 34 (10) , 1666-1672
Potential use of electrohysterography in obstetrics: a review article
Monitoring the uterine contraction during pregnancy is necessary to monitor labor progress, fetal and maternal well-being, and uterine activity. The aim of this review was to evaluate the performance of electrohysterography and to analyze the nature of uterine contraction. A search was undertaken using PubMed, Embase, and ClinicalTrials.gov database from 1 January 1950 to 1 November 2018. Search terms include: "Uterine" or "Uterus" or "Labor" or "Labour" and "electrical activity" or "electrohysterogram" or "electrohysterograph". Reviewing the literature, electrohysterography showed a higher sensitivity for uterine contraction detection and was independent of body mass index, abdominal wall thickness, or maternal position enabling monitoring obese patients as well. Electrohysterography can enhance uterine monitoring throughout labor because of its noninvasiveness, adhesive properties, and reduced obesity sensitiveness. Electrohysterography should be available to safely improve intrapartum monitoring instead of the invasive intrauterine pressure catheter.
- 1 May 2019
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 74 (5) , 298-302
Update on the Prenatal Diagnosis and Outcomes of Fetal Bilateral Renal Agenesis
Importance: Bilateral renal agenesis is a rare congenital anomaly associated with poor prognosis. Objective: The aims of this article are to review and summarize evidence on prenatal diagnosis and outcomes of bilateral renal agenesis. Evidence Acquisition: A search was undertaken using PubMed and ClinicalTrials.gov databases from January 1, 1998, to September 1, 2018. Search terms include “prenatal diagnosis” OR “outcomes” AND “bilateral renal agenesis.” Search was limited to English language. Results: Fetal ultrasonography is the primary imaging modality for prenatal diagnosis of fetal urogenital tract abnormalities. However, ultrasonography is limited by several factors; it is operator dependent and associated with small field of view, has limited soft-tissue acoustic contrast, and is also influenced by patient habitus and fetal position. Color Doppler ultrasonography can be used as an adjunct to exclude bilateral renal agenesis by visualizing renal arteries. In the literature, prenatal magnetic resonance imaging has been reported to be equal to or superior to prenatal ultrasonography. Bilateral renal agenesis with oligohydramnios/anhydramnios is associated with a poor prognosis; perinatal death occurs secondary to pulmonary hypoplasia in the majority of cases. Conclusions: Ultrasonography in combination with color Doppler ultrasonography permits the fetal urinary tract to be assessed in the first and early second trimester of gestation. The magnetic resonance imaging can be used as a complementary adjunctive modality in equivocal or inconclusive ultrasonographic findings. Target Audience: Obstetricians and gynecologists, family physicians. Learning Objectives: After completing this activity, the learner should be able to describe the natural history of fetuses with bilateral renal agenesis; explain to patients the accuracy and limitations of the prenatal diagnosis of the anomaly; and counsel patients regarding the perinatal outcome and prognosis of fetuses with this condition.
- 1 May 2019
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 74 (5) , 298-302
Update on the Prenatal Diagnosis and Outcomes of Fetal Bilateral Renal Agenesis
Importance: Bilateral renal agenesis is a rare congenital anomaly associated with poor prognosis. Objective: The aims of this article are to review and summarize evidence on prenatal diagnosis and outcomes of bilateral renal agenesis. Evidence Acquisition: A search was undertaken using PubMed and ClinicalTrials.gov databases from January 1, 1998, to September 1, 2018. Search terms include “prenatal diagnosis” OR “outcomes” AND “bilateral renal agenesis.” Search was limited to English language. Results: Fetal ultrasonography is the primary imaging modality for prenatal diagnosis of fetal urogenital tract abnormalities. However, ultrasonography is limited by several factors; it is operator dependent and associated with small field of view, has limited soft-tissue acoustic contrast, and is also influenced by patient habitus and fetal position. Color Doppler ultrasonography can be used as an adjunct to exclude bilateral renal agenesis by visualizing renal arteries. In the literature, prenatal magnetic resonance imaging has been reported to be equal to or superior to prenatal ultrasonography. Bilateral renal agenesis with oligohydramnios/anhydramnios is associated with a poor prognosis; perinatal death occurs secondary to pulmonary hypoplasia in the majority of cases. Conclusions: Ultrasonography in combination with color Doppler ultrasonography permits the fetal urinary tract to be assessed in the first and early second trimester of gestation. The magnetic resonance imaging can be used as a complementary adjunctive modality in equivocal or inconclusive ultrasonographic findings. Target Audience: Obstetricians and gynecologists, family physicians. Learning Objectives: After completing this activity, the learner should be able to describe the natural history of fetuses with bilateral renal agenesis; explain to patients the accuracy and limitations of the prenatal diagnosis of the anomaly; and counsel patients regarding the perinatal outcome and prognosis of fetuses with this condition.
- 5 November 2018
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 38 (11) , 6507-6511
Comparison of Primary Tumor Size in Stage I and III Epithelial Ovarian Cancer
Background: Two studies have found primary ovarian carcinomas in stage I disease to be larger than those in stage III. Thus, these stages may represent different tumor entities. Materials and Methods: The clinical data from 553 patients operated on between 1985 and 2012 for epithelial ovarian cancer were retrospectively analyzed. Results: Primary lesions including invasive, borderline and benign components were significantly larger in stage I compared to stage III disease (p<0.001). However, the maximum diameter of invasive components in those with stage III disease were significantly larger than in those with stage I disease (p=0.001). The size of the invasive component was not associated with the largest size of intraperitoneal metastasis. Conclusion: We were only, in part, able to reproduce the data from the two smaller published studies. The prognosis of patients with stage III disease strongly depends on the size of intraperitoneal metastases.
- 5 November 2018
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 38 (11) , 6507-6511
Comparison of Primary Tumor Size in Stage I and III Epithelial Ovarian Cancer
Background: Two studies have found primary ovarian carcinomas in stage I disease to be larger than those in stage III. Thus, these stages may represent different tumor entities. Materials and Methods: The clinical data from 553 patients operated on between 1985 and 2012 for epithelial ovarian cancer were retrospectively analyzed. Results: Primary lesions including invasive, borderline and benign components were significantly larger in stage I compared to stage III disease (p<0.001). However, the maximum diameter of invasive components in those with stage III disease were significantly larger than in those with stage I disease (p=0.001). The size of the invasive component was not associated with the largest size of intraperitoneal metastasis. Conclusion: We were only, in part, able to reproduce the data from the two smaller published studies. The prognosis of patients with stage III disease strongly depends on the size of intraperitoneal metastases.